National Medical Health Card Systems Inc

National Medical Health Card Systems — Conference Presentation (June 2006)

26 slides from National Medical Health Card Systems's conference presentation, Jun 22, 2006

  1. Slide 1: National Medical Health Card Systems, Inc.

    National Medical National Medical Health Card Systems, Inc. Health Card Systems, Inc. (NASDAQ: NMHC) (NASDAQ: NMHC) Exhibit 99.1

  2. Slide 2: Safe Harbor Statement

    Safe Harbor Statement Safe Harbor Statement This slide presentation contains forward-looking projections which involve known and unknown risks and uncertainties or other factors that may cause actual results, performance or achievements to be materially different from any future results, performance

  3. Slide 3: Investment Highlights

    Investment Highlights Investment Highlights • Middle-market leader, differentiated by in-house capabilities, flexibility and superior ability to manage pharmaceutical costs • Opportunity to cross sell high margin services to existing clients • Investments in infrastructure set stage for margin expan

  4. Slide 4: What is a PBM?

    What is a PBM? What is a PBM? PBMs provide custom-tailored prescription benefit plans and formularies that help reduce their clients’ drug costs Patient Payer Pharmaceutical company Pharmacy Physician

  5. Slide 5: Why use a PBM?

    Why use a PBM? Why use a PBM? • Purchasing power • Benefit design consulting • Substitution of preferred/generic brands • Specialty pharmacy services • Home delivery services

  6. Slide 6: Prescription Growth Trends

    Prescription Growth Trends Prescription Growth Trends 9.0 6.5 5.6 4.5 2.6 2.3 3.3 MAT June % Change in Total Prescriptions Dispensed Source: IMS Health: National Prescription Audit (NPA) PIUS, Monthly Rx Audit, July 2005

  7. Slide 7: Industry Drivers

    Industry Drivers Industry Drivers Increased adoption of mandatory mail programs Home delivery accounts for 17% of all prescription sales Home Delivery Increased prescription use due to Medicare Part D By 2010, seniors aged 55-64 will increase by nearly 50% Drug spending increasing 10-12% annually PB

  8. Slide 8: Middle-Market Opportunity

    Big 3 PBMs Middle-Market Opportunity Middle-Market Opportunity • Most Americans employed with middle market employers • Historically underserved by larger PBMs – “Shell game” perception • Loyal purchasers/higher margin • High degree of fragmentation of smaller PBMs Middle Market Multiple small/regio

  9. Slide 9: What Do Middle Market Clients Want?

    What Do Middle Market Clients Want? What Do Middle Market Clients Want? • One stop shopping • Transparent business model • Patient/clinical management • Specialty strategies for high cost injectables • Low price Flexibility, Flexibility, Flexibility

  10. Slide 10: NMHC Total Healthcare Solutions

    4% NMHC 47 Total Healthcare Solutions

  11. Slide 11: PBM Services

    PBM Services PBM Services • Claims Management • Pharmacy Network • Benefit Design Consultation • Drug Review & Analysis • Formulary Design and Disease Information Services • Data Access, Reporting & Information Analysis • Physician Profiling Preferred Partnership Program offers complete pass through

  12. Slide 12: Home Delivery

    Home Delivery Home Delivery • Mail service pharmacy for chronic therapy medications • Launched July 2003 • 30,000 square foot facility • Currently at 20% of capacity Home Delivery

  13. Slide 13: Specialty Pharmacy

    Specialty Pharmacy Specialty Pharmacy • High cost self-injected medications and compounded prescriptions that require special handling – Represents 1% of population and 15% of total drug spend – Strong biotech pipeline will lead to increased utilization • Built around case management, not product fu

  14. Slide 14: Risk Management

    Risk Management Risk Management • Level 1: Pharmacy Cost Control – Full suite of Rx management services – Measurable savings for cost-conscious plans • Level 2: Pharmacy Cost Control+ – Rx management tuned through Rx-based risk prediction – Incremental savings for progressive plans • Level 3: Pharma

  15. Slide 15: Total Healthcare Solutions

    Total Healthcare Solutions Total Healthcare Solutions Unmatched Middle-Market Capabilities

  16. Slide 16: Customer Composition

    33% 18% 24% 22% 3% Customer Composition Customer Composition 33% 18% 24% 22% 3% Managed Medicaid Third Party Administrators Taft-Hartley Other Managed Care

  17. Slide 17: Competitive Advantage: Customer Services

    Competitive Advantage: Customer Services Competitive Advantage: Customer Services 6.5 7.5 8.5 9.5 Retail Pharmacy Network Claim Processing Management Reports Delivering Promised Services Overall Service and Performance Eligibility Management Drug Utilization Management Customer and Member Service De

  18. Slide 18: Competitive Advantage: Medicare Part D

    Competitive Advantage: Medicare Part D Competitive Advantage: Medicare Part D • Unique capabilities among middle-market PBMs • MA-PD Medicare plan sponsor support – Complete back office operational support – Clinical, systems, CMS communications and policy support • Employer and union support – Medi

  19. Slide 19: Competitive Advantages

    Competitive Advantages Competitive Advantages • Proven track record and industry leadership in controlling drug cost inflation • Greater flexibility and highest rated in customer satisfaction • Fair and transparent reporting • Comprehensive in-house offerings and risk management solutions • Medicare

  20. Slide 20: Growth Initiatives

    Growth Initiatives Growth Initiatives • New client acquisition – Expanding senior sales team • New senior VP sales – Attack 3 primary verticals: • Third-Party Administrator & Employer • Taft-Hartley (Union) • Managed Care – Competing for larger accounts with Integrated Services Suite as key differen

  21. Slide 21: Acquisition Strategy

    Big 3 NMHC Acquisition Strategy Acquisition Strategy • Acquire Small/Regional PBMs – Easy entry but significant challenges to scale – Accelerating consolidation with regional PBMs unable to meet Part D requirements • Acquire Specialty Pharmacy Co’s – Increase purchasing power – Expand geographic rea

  22. Slide 22: NMHC Performance

    Five-year Revenue CAGR of 37% Five-year EBITDA CAGR of 53% FY’05 Net Income Up 31% Year Over Year** Profitable Every Year Since 1996* $3.2 $3.7 $11.2 $16.4 $19.3 $27.0 $1.6 $1.2 $4.5 $6.4 $9.5 $12.4 FY00 FY01 FY02 FY03 FY04 FY05 EBITDA* Net Income Revenue $167.7 $272.1 $459.8 $573.3 $651.1 $800.1 ($

  23. Slide 23: Balance Sheet Highlights

    Cash & Cash Equivalents Total Assets Total Liabilities 03/31/06 6/30/05 $ 10,244 $ 7,272 Total Current Assets 180,374 166,798 298,678 283,931 Total Current Liabilities 192,108 191,235 199,846 198,213 Total Redeemable Preferred Equity and Common Stockholders’ Equity 98,832 85,718 ($ in thousands) Bal

  24. Slide 24: Investment Highlights

    Investment Highlights Investment Highlights • Middle-market leader, differentiated by in-house capabilities, flexibility and superior ability to manage pharmaceutical costs • Opportunity to cross sell high margin services to existing clients • Investments in infrastructure set stage for margin expan

  25. Slide 25: EBITDA Reconciliation

    EBITDA Reconciliation EBITDA Reconciliation Cash Flow From Operations $5,803 $12,091 $12,415 $15,868 $24,060 $10,322 Provision for Income Taxes 1,247 2,900 4,602 5,524 8,031 Interest (Income) Expense, Net (922) (877) Net Change in Assets and Liabilties (884) (6,644) (4,404) (4,613) (7,823) 11,988 No

  26. Slide 26: EBITDA Reconciliation

    EBITDA Reconciliation EBITDA Reconciliation Three of the Company’s financial covenants under its revolving credit facility (“Facility”) are based upon the EBITDA (earnings before interest, taxes, depreciation and amortization) generated by the Company over specified periods of time. These covenants,

National Medical Health Card Systems — Conference Presentation (June 2006) on 6ix